
3 Flexible Hoses Maker, Biscuits and Bakery Brand and Pharmaceuticals Company Stocks With a Strong Future Roadmap: Aeroflex Industries, Britannia Industries and Alembic Pharmaceuticals
Aeroflex Industries, Britannia Industries and Alembic Pharmaceuticals: ROE of 11.9% to 49.6% and FY22 to FY26 revenue CAGR of 7.8% to 16.5%. Prices as of 16 Nov 2026.
Updated: 17 Nov 2026 • 3:03 pm
Posted by:

Quick Answer
The three flexible hose, biscuit and generic drug stocks to watch are Aeroflex Industries, Britannia Industries and Alembic Pharmaceuticals. Their return on equity ranges from 11.9% to 49.6%, and their revenue compound annual growth from FY22 to FY26 ranges from 7.8% to 16.5%. Britannia Industries has the highest return on equity at 49.6%, while Aeroflex Industries has the fastest revenue growth at 16.5% a year. Prices are based on the 16 November 2026 close, and this article is educational, not investment advice.
Flexible hose, biscuit and generic drug stocks let investors follow companies that serve a growing part of the Indian economy. Aeroflex Industries, Britannia Industries and Alembic Pharmaceuticals cover a flexible hoses maker, a biscuits and bakery brand and a pharmaceuticals company.
This list covers three flexible hose, biscuit and generic drug stocks with complete current figures: Aeroflex Industries, Britannia Industries and Alembic Pharmaceuticals. Every figure comes from the latest reported financials and the 16 November 2026 market close. Companies without complete current figures were left out.
Click Here – Get Free Investment Predictions
What Are Flexible Hose, Biscuit and Generic Drug Stocks?
Flexible hose, biscuit and generic drug stocks are listed companies that make stainless steel flexible hoses for industry, make biscuits, cakes and dairy products for households, and make medicines and active ingredients for India and global markets. Their earnings depend on industrial orders, household demand and medicine demand.
Flexible Hose, Biscuit and Generic Drug Stocks at a Glance
| Company | CMP (Rs) | Market Cap (Rs Cr) | P/E | Industry P/E | ROE (%) | D/E |
|---|---|---|---|---|---|---|
| Aeroflex Industries | 494.1 | 6,368 | 94.9 | 20.4 | 12.4 | 0.02 |
| Britannia Industries | 4,754 | 113,329 | 43.4 | 33.9 | 49.6 | 0.27 |
| Alembic Pharmaceuticals | 1,057.1 | 14,914 | 21.6 | 35.7 | 11.9 | 0.25 |
On valuation, Alembic Pharmaceuticals trades at a P/E below the industry P/E, while Aeroflex Industries and Britannia Industries trade above it, which reflects the growth the market already expects. Readers comparing flexible hose, biscuit and generic drug stocks should look at return on equity and debt together, since a high return earned with low debt is easier to sustain.
Why Do Flexible Hose, Biscuit and Generic Drug Stocks Have a Strong Roadmap in India?
Flexible hose, biscuit and generic drug stocks have a strong roadmap in India because wider industrial use of flexible hoses, steady household spending on packaged foods and rising demand for medicines keep widening the market for these companies.
- Flexible hoses. Plants need safe fluid and gas lines.
- Biscuits and bakery. Households buy trusted packaged foods.
- Pharmaceuticals. Patients need dependable formulations.
Why Aeroflex Industries Features Among These Flexible Hose, Biscuit and Generic Drug Stocks
Among the flexible hose, biscuit and generic drug stocks on this list, Aeroflex Industries makes stainless steel flexible flow solutions such as flexible hoses, braided hoses and assemblies used in aerospace, pharma, steel and other industries.
Revenue rose from Rs 241 crore in FY22 to Rs 443 crore in FY26, a compound annual growth rate of 16.5%. Net profit grew from Rs 27.5 crore in FY22 to Rs 55.5 crore in FY26, which works out to a compound annual growth rate of 19.2%.
The company has a return on equity of 12.4%, a debt to equity ratio of 0.02 and a market capitalisation of Rs 6,368 crore. The stock trades at a P/E of 94.9, above the industry P/E of 20.4.
Roadmap: The company is expanding capacity and widening its range of high-specification flexible hoses for aerospace and industrial customers in India and overseas. Specialised products and long approvals support its customer relationships.
What to watch: Follow capacity expansion, export orders and demand from aerospace customers.
Why Britannia Industries Features Among These Flexible Hose, Biscuit and Generic Drug Stocks
Among the steel hoses, bakery brand and tablet maker shares on this list, Britannia Industries is one of India's leading food companies, making biscuits, bread, cakes, rusk and dairy products under brands such as Good Day, Marie Gold, Tiger and NutriChoice.
The company has a return on equity of 49.6%, a debt to equity ratio of 0.27 and a market capitalisation of Rs 113,329 crore. The stock trades at a P/E of 43.4, above the industry P/E of 33.9.
Revenue rose from Rs 14,359 crore in FY22 to Rs 19,376 crore in FY26, a compound annual growth rate of 7.8%. Net profit grew from Rs 1,516 crore in FY22 to Rs 2,537 crore in FY26, which works out to a compound annual growth rate of 13.7%. In the June 2026 quarter, revenue grew 8.2% year on year to Rs 5,061 crore, while net profit rose 14.1% to Rs 593 crore.
Roadmap: The company sells through a vast distribution network that reaches millions of outlets and is widening into croissants, cakes and adjacent categories. Investments in new factories and premium products add to its reach.
What to watch: Check the growth in the premium and adjacent categories and wheat and edible oil prices.
Why Alembic Pharmaceuticals Features Among These Flexible Hose, Biscuit and Generic Drug Stocks
Among the three companies on this list, Alembic Pharmaceuticals is a Vadodara-based drug maker that sells generic formulations in the United States, branded medicines in India and active ingredients to other manufacturers.
Revenue rose from Rs 5,356 crore in FY22 to Rs 7,399 crore in FY26, a compound annual growth rate of 8.4%. Net profit grew from Rs 521 crore in FY22 to Rs 671 crore in FY26, which works out to a compound annual growth rate of 6.5%.
In the June 2026 quarter, revenue grew 26.1% year on year to Rs 2,165 crore, while net profit rose 12.2% to Rs 172 crore. The company has a return on equity of 11.9%, a debt to equity ratio of 0.25 and a market capitalisation of Rs 14,914 crore. The stock trades at a P/E of 21.6, below the industry P/E of 35.7.
Roadmap: The company is moving into complex generics such as injectables and ophthalmic products, which tend to face less competition. Steady growth in the India branded business adds stability.
What to watch: Follow new approvals in the United States, the pace of complex generic launches and domestic growth.
Aeroflex Industries vs Britannia Industries vs Alembic Pharmaceuticals on Key Financials
The table below sets the three flexible hose, biscuit and generic drug stocks side by side on revenue, profit and margin, using reported figures.
| Company | FY22 Revenue (Rs Cr) | FY26 Revenue (Rs Cr) | Revenue CAGR (FY22-FY26) | FY26 Net Profit (Rs Cr) | FY26 Net Margin |
|---|---|---|---|---|---|
| Aeroflex Industries | 241 | 443 | 16.5% | 55.5 | 12.5% |
| Britannia Industries | 14,359 | 19,376 | 7.8% | 2,537 | 13.1% |
| Alembic Pharmaceuticals | 5,356 | 7,399 | 8.4% | 671 | 9.1% |
Britannia Industries posts the highest return on equity in this group at 49.6%. Britannia Industries has the largest FY26 revenue at Rs 19,376 crore, and Aeroflex Industries shows the fastest revenue growth with a 16.5% compound annual rate. A useful habit with flexible hose, biscuit and generic drug stocks is to check each new quarterly result against the capacity plans the company described earlier.
Key Risks to Check Before Investing in Flexible Hose, Biscuit and Generic Drug Stocks
Every theme carries risks that deserve a check before any decision. For these flexible hose, biscuit and generic drug stocks, the main points are: Long-term steel hoses, bakery brand and tablet maker shares holders usually track revenue growth, margins and cash flow side by side rather than relying on a single ratio.
- Order timing. Project awards can shift between periods.
- Raw material costs. Ingredient and packaging prices can move margins.
- Regulatory approvals. Plant inspections and approvals can affect supplies.
Treat this list as a starting point for research and not as a recommendation. Read the latest results presentation, check the management commentary on order books or capacity plans, and compare each company with its peers before you decide anything.
Use the Univest Stock Screener to filter flexible hose, biscuit and generic drug stocks by market capitalisation, P/E, ROE and growth, and build your own shortlist.
Final Thoughts on Flexible Hose, Biscuit and Generic Drug Stocks
Flexible hose, biscuit and generic drug stocks reward investors who follow demand trends, order books and margins together. Aeroflex Industries, Britannia Industries and Alembic Pharmaceuticals each have a clear plan to grow. Based on the 16 November 2026 close, Aeroflex Industries trades at Rs 494.1, Britannia Industries at Rs 4,754 and Alembic Pharmaceuticals at Rs 1,057.1. Valuation matters as much as growth, so compare each company's P/E with its industry P/E before adding any of these flexible hose, biscuit and generic drug stocks to a watchlist.
Download the Univest iOS App or Univest Android App to track flexible hose, biscuit and generic drug stocks, set price alerts and get research-backed stock ideas.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).
What are flexible hose, biscuit and generic drug stocks?
Ans. Flexible hose, biscuit and generic drug stocks are listed companies that make stainless steel flexible hoses for industry, make biscuits, cakes and dairy products for households, and make medicines and active ingredients for India and global markets. Their earnings depend on industrial orders, household demand and medicine demand. This list looks at three of them, Aeroflex Industries, Britannia Industries and Alembic Pharmaceuticals, using reported FY22 to FY26 financials and the 16 November 2026 closing prices.
Which flexible hose, biscuit and generic drug stocks are covered in this list?
Ans. This list covers Aeroflex Industries, Britannia Industries and Alembic Pharmaceuticals. Based on the 16 November 2026 close, Aeroflex Industries traded at Rs 494.1, Britannia Industries at Rs 4,754 and Alembic Pharmaceuticals at Rs 1,057.1. Their return on equity ranges from 11.9% to 49.6%, and their revenue compound annual growth from FY22 to FY26 ranges from 7.8% to 16.5%.
Why do flexible hose, biscuit and generic drug stocks have a strong future roadmap in India?
Ans. Flexible hose, biscuit and generic drug stocks have a strong roadmap in India because wider industrial use of flexible hoses, steady household spending on packaged foods and rising demand for medicines keep widening the market for these companies. The main drivers are as follows. Flexible hoses. Plants need safe fluid and gas lines. Biscuits and bakery. Households buy trusted packaged foods. Pharmaceuticals. Patients need dependable formulations. Together these factors give the companies on this list a visible path for growth over the coming years.
How has Aeroflex Industries performed financially?
Ans. Revenue rose from Rs 241 crore in FY22 to Rs 443 crore in FY26, a compound annual growth rate of 16.5%. Net profit grew from Rs 27.5 crore in FY22 to Rs 55.5 crore in FY26, which works out to a compound annual growth rate of 19.2%. The company has a return on equity of 12.4%, a debt to equity ratio of 0.02 and a market capitalisation of Rs 6,368 crore. The stock trades at a P/E of 94.9, above the industry P/E of 20.4. Looking ahead, the company is expanding capacity and widening its range of high-specification flexible hoses for aerospace and industrial customers in India and overseas. Specialised products and long approvals support its customer relationships.
How has Britannia Industries performed financially?
Ans. Revenue rose from Rs 14,359 crore in FY22 to Rs 19,376 crore in FY26, a compound annual growth rate of 7.8%. Net profit grew from Rs 1,516 crore in FY22 to Rs 2,537 crore in FY26, which works out to a compound annual growth rate of 13.7%. In the June 2026 quarter, revenue grew 8.2% year on year to Rs 5,061 crore, while net profit rose 14.1% to Rs 593 crore. The company has a return on equity of 49.6%, a debt to equity ratio of 0.27 and a market capitalisation of Rs 113,329 crore. The stock trades at a P/E of 43.4, above the industry P/E of 33.9. Looking ahead, the company sells through a vast distribution network that reaches millions of outlets and is widening into croissants, cakes and adjacent categories. Investments in new factories and premium products add to its reach.
How has Alembic Pharmaceuticals performed financially?
Ans. Revenue rose from Rs 5,356 crore in FY22 to Rs 7,399 crore in FY26, a compound annual growth rate of 8.4%. Net profit grew from Rs 521 crore in FY22 to Rs 671 crore in FY26, which works out to a compound annual growth rate of 6.5%. In the June 2026 quarter, revenue grew 26.1% year on year to Rs 2,165 crore, while net profit rose 12.2% to Rs 172 crore. The company has a return on equity of 11.9%, a debt to equity ratio of 0.25 and a market capitalisation of Rs 14,914 crore. The stock trades at a P/E of 21.6, below the industry P/E of 35.7. Looking ahead, the company is moving into complex generics such as injectables and ophthalmic products, which tend to face less competition. Steady growth in the India branded business adds stability.
What risks should investors check before buying flexible hose, biscuit and generic drug stocks?
Ans. Investors should check a few risks before buying flexible hose, biscuit and generic drug stocks. Order timing. Project awards can shift between periods. Raw material costs. Ingredient and packaging prices can move margins. Regulatory approvals. Plant inspections and approvals can affect supplies. Reading the latest results presentation and comparing each company with its peers helps judge how these risks apply to each stock.
Is this list of flexible hose, biscuit and generic drug stocks investment advice?
Ans. No. This article is educational and uses publicly available data as of the 16 November 2026 close. Please verify figures on NSE and BSE, read company filings and consult a SEBI registered adviser before investing. Univest is SEBI registered research analyst INH000013776.
Recent Articles

High Dividend Yield Stocks in India: Vedanta, Hindustan Zinc, Coal India and CESC Checked on 17 November 2026
17 November 2026

Top Mid-Cap Metal Stocks Compared: Jindal Stainless vs Gravita vs HEG vs Graphite India vs MOIL on Price, Valuation, Q2 FY27 Results and Risks
17 November 2026

Top Mid-Cap Hospital Stocks Compared: Rainbow Children vs HCG vs Jupiter Life Line vs KIMS vs Narayana Hrudayalaya on Price, Valuation, Q2 FY27 Results and Risks
17 November 2026

Top Mid-Cap Capital Goods Stocks Compared: Elgi Equipments vs GMM Pfaudler vs Grindwell Norton vs AIA Engineering vs Cummins India on Price, Valuation, Q2 FY27 Results and Risks
17 November 2026
Note: This blog is for information purpose only. Investments and trading are subject to market risks, read all scheme related documents carefully.
Reviews
Recent Posts
High Dividend Yield Stocks in India: Vedanta, Hindustan Zinc, Coal India and CESC Checked on 17 November 2026
Top Mid-Cap Metal Stocks Compared: Jindal Stainless vs Gravita vs HEG vs Graphite India vs MOIL on Price, Valuation, Q2 FY27 Results and Risks
Top Mid-Cap Hospital Stocks Compared: Rainbow Children vs HCG vs Jupiter Life Line vs KIMS vs Narayana Hrudayalaya on Price, Valuation, Q2 FY27 Results and Risks
Top Mid-Cap Capital Goods Stocks Compared: Elgi Equipments vs GMM Pfaudler vs Grindwell Norton vs AIA Engineering vs Cummins India on Price, Valuation, Q2 FY27 Results and Risks
Top Mid-Cap Auto Stocks Compared: Hyundai Motor India vs Force Motors vs JBM Auto vs Escorts Kubota vs Olectra on Price, Valuation, Q2 FY27 Results and Risks
Popular this week
Top Two-Wheeler Stocks Compared: Hero MotoCorp vs Bajaj Auto vs Eicher Motors vs TVS Motor vs Atul Auto on Price, Valuation, Q2 FY27 Results and Risks

Uniresearch Global Pvt Ltd
Research Analyst
SEBI Registration Number — INH000013776
Uniresearch is a subsidiary of Univest Communication Technologies Private Limited
Company Address: Registered Address: Ground Floor, Unitech Commercial Tower 2, Block B, Greenwood City, Unit 1-3, Sector 45, Gurugram, Haryana 122003
Write to us : support@univest.in, compliance@univest.in
Verify on SEBI registry →RESEARCH ANALYST
Get SEBI Registered
advice on the stocks
trending today.
Get 3 FREE Trade Ideas
for Startups Accelerator 2024
Trusted by 1Cr Indians
Awarded No.1 by Economic Times





